Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions
| Autor: | Karen L. Stein, Kathryn J. Aikin, Jennifer Berktold, Victoria J. Hoverman, Helen Sullivan |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Direct-to-consumer advertising Prescription Drugs Prescription drug Drug Industry Health care provider media_common.quotation_subject Branded drug Direct-to-Consumer Advertising Drug Prescriptions 01 natural sciences Patient care 03 medical and health sciences 0302 clinical medicine Promotion (rank) Advertising Surveys and Questionnaires Health care Humans Medicine 030212 general & internal medicine 0101 mathematics Medical prescription media_common business.industry 010102 general mathematics Public Health Environmental and Occupational Health Family Practice business |
| Zdroj: | The Journal of the American Board of Family Medicine. 33:279-283 |
| ISSN: | 1558-7118 1557-2625 |
| DOI: | 10.3122/jabfm.2020.02.190278 |
| Popis: | Background: Direct-to-consumer prescription drug advertising is prevalent and affects patient care. Previous research that examined its effect on the patient-provider relationship predates many changes in the advertising and medical landscape that have occurred in the last decade, such as the rise in online promotion and the push for value-based medicine. Methods: We conducted a nationally representative mail-push-to-web survey of 1744 US adults in 2017 to explore how patients view the effects of direct-to-consumer prescription drug advertising on patient-provider interactions. Results: Most respondents (76%) said they were likely to ask a health care provider about advertised drugs; 26% said they had already done so. Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Few respondents (5%) reported that advertising had caused conflict with a health care provider, 16% said it had caused them to question their provider’s advice, and 23% said they were likely to look for a different provider if their provider refused to prescribe a requested brand name drug. Discussion: These results suggest that direct-to-consumer advertising is driving some patients to discuss specific products with their health care providers but that most patients do not believe advertising has a negative influence on the patient-provider interaction itself. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|